Key facts
- This page summarizes Steve O'Loughlin's Form 4 filing for Actinium Pharmaceuticals, Inc. (ATNM).
- 9 reported transactions and 9 derivative rows are listed below.
- Accepted by SEC: 02 Apr 2025, 18:20.
Steve O'Loughlin - 31 Mar 2025 Form 4 Insider Report for Actinium Pharmaceuticals, Inc. (ATNM)
- Reporting relationship
- Chief Financial Officer
- Issuer ticker
- ATNM
- Reported as of
- 31 Mar 2025
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 02 Apr 2025, 18:20:36 UTC
- Prior SEC filing
- 29 Dec 2023
- Next SEC filing
- 04 Mar 2026
- Source filing
- View source filing
- Reporting owner signature
- /s/ Steve O'Loughlin
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Steve O'Loughlin filed Form 4 for Actinium Pharmaceuticals, Inc. (ATNM) on 02 Apr 2025.
Change
- Previous filing in this sequence was filed on 29 Dec 2023.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
ATNM
transaction
Derivative
Stock Option (Right to Buy)
Disposed to Issuer
- Transaction value
- $0
- Shares
- -3,333
- Change %
- -100%
- Price
- $0.000000
- Shares after
- 0
- Date
- 31 Mar 2025
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 3,333
- Exercise price
- $53.70
- Footnotes
- F1
ATNM
transaction
Derivative
Stock Option (Right to Buy)
Disposed to Issuer
- Transaction value
- $0
- Shares
- -1,666
- Change %
- -100%
- Price
- $0.000000
- Shares after
- 0
- Date
- 31 Mar 2025
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 1,666
- Exercise price
- $59.70
- Footnotes
- F1
ATNM
transaction
Derivative
Stock Option (Right to Buy)
Disposed to Issuer
- Transaction value
- $0
- Shares
- -3,333
- Change %
- -100%
- Price
- $0.000000
- Shares after
- 0
- Date
- 31 Mar 2025
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 3,333
- Exercise price
- $41.70
- Footnotes
- F1
ATNM
transaction
Derivative
Stock Option (Right to Buy)
Disposed to Issuer
- Transaction value
- $0
- Shares
- -8,833
- Change %
- -100%
- Price
- $0.000000
- Shares after
- 0
- Date
- 31 Mar 2025
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 8,833
- Exercise price
- $23.49
- Footnotes
- F1
ATNM
transaction
Derivative
Stock Option (Right to Buy)
Disposed to Issuer
- Transaction value
- $0
- Shares
- -13,333
- Change %
- -100%
- Price
- $0.000000
- Shares after
- 0
- Date
- 31 Mar 2025
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 13,333
- Exercise price
- $6.96
- Footnotes
- F1
ATNM
transaction
Derivative
Stock Option (Right to Buy)
Disposed to Issuer
- Transaction value
- $0
- Shares
- -59,066
- Change %
- -100%
- Price
- $0.000000
- Shares after
- 0
- Date
- 31 Mar 2025
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 59,066
- Exercise price
- $9.55
- Footnotes
- F1
ATNM
transaction
Derivative
Stock Option (Right to Buy)
Disposed to Issuer
- Transaction value
- $0
- Shares
- -107,463
- Change %
- -100%
- Price
- $0.000000
- Shares after
- 0
- Date
- 31 Mar 2025
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 107,463
- Exercise price
- $6.07
- Footnotes
- F1
ATNM
transaction
Derivative
Stock Option (Right to Buy)
Disposed to Issuer
- Transaction value
- $0
- Shares
- -256,438
- Change %
- -100%
- Price
- $0.000000
- Shares after
- 0
- Date
- 31 Mar 2025
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 256,438
- Exercise price
- $4.96
- Footnotes
- F1
ATNM
transaction
Derivative
Stock Option (Right to Buy)
Disposed to Issuer
- Transaction value
- $0
- Shares
- -253,123
- Change %
- -100%
- Price
- $0.000000
- Shares after
- 0
- Date
- 31 Mar 2025
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 253,123
- Exercise price
- $5.00
- Footnotes
- F1
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 1 footnote
Footnote F1
Pursuant to that certain Option Cancellation and Release Agreement, dated as of March 31, 2025, by and between the Issuer and the Reporting Person, the Reporting Person agreed to cancel the reported stock options to purchase shares of common stock, par value $0.001 per share, effective March 31, 2025, in exchange for nominal consideration.